The chimeric FUS‐DDIT3 fusion protein, a hallmark of MLS, acts as an aberrant transcription factor and has been shown to drive MLS development in mice (Kuroda et al, 1997; Riggi et al, 2006). This evidence concerns the gene FUS and McLeod neuroacanthocytosis syndrome.